SkinMedica

MAP Pharmaceuticals (NASDAQ: MAPP) is blasting into orbit today on word the company will be acquired by Irvine, California drug manufacturer Allergan (NYSE: AGN). On Tuesday, MAP announced Allergan will purchase 100 percent of its shares at $25 each. Overall, the value of the purchase is an...